Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system

AIMS: To investigate the cost-effectiveness of once-daily insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy in patients with type 2 diabetes not meeting glycemic targets on basal insulin from a healthcare payer perspective in Slovakia. METHODS: Long-term clinical and economic outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Psota, Marek, Psenkova, Maria Bucek, Racekova, Natalia, Ramirez de Arellano, Antonio, Vandebrouck, Tom, Hunt, Barnaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731336/
https://www.ncbi.nlm.nih.gov/pubmed/29276398
http://dx.doi.org/10.2147/CEOR.S143127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731336/
https://www.ncbi.nlm.nih.gov/pubmed/29276398
http://dx.doi.org/10.2147/CEOR.S143127

Ejemplares similares